Amgen's MariTide shows promising weight loss results in Phase II for type 2 diabetes. Find out why AMGN stock remains as a strong buy for long-term investors.
Medicines like semaglutide have proven remarkably effective in helping people lose ... over half the world’s population is expected to be overweight or living with obesity by 2035, the obesity crisis ...